Base de dados : MEDLINE
Pesquisa : D27.505.696.875.360 [Categoria DeCS]
Referências encontradas : 3655 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 366 ir para página                         

  1 / 3655 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
[PMID]:29236367
[Au] Autor:Gendron F; Bérubé J; Guilbert É; Leboeuf M; Ouellet S; Risi C; Roy G; Steben M; Wagner MS; Martin RC
[Ad] Endereço:Institut national de santé publique du Québec, Québec, Canada.
[Ti] Título:L'ajustement thérapeutique selon le Protocole de contraception du Québec..
[So] Source:Perspect Infirm;14(2):31-34, 2017 Mar-Apr.
[Is] ISSN:1708-1890
[Cp] País de publicação:Canada
[La] Idioma:fre
[Mh] Termos MeSH primário: Anticoncepcionais
Dispositivos Anticoncepcionais
[Mh] Termos MeSH secundário: Seres Humanos
Serviços de Enfermagem
Quebeque
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Contraceptive Agents)
[Em] Mês de entrada:1803
[Cu] Atualização por classe:180306
[Lr] Data última revisão:
180306
[Sb] Subgrupo de revista:N
[Da] Data de entrada para processamento:171214
[St] Status:MEDLINE


  2 / 3655 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29437567
[Au] Autor:Pillai SW
[Ad] Endereço:Edgware Community Hospital, Edgware HA8 0NY, UK.
[Ti] Título:Cutting contraceptive services will have dire consequences.
[So] Source:BMJ;360:k285, 2018 02 05.
[Is] ISSN:1756-1833
[Cp] País de publicação:England
[La] Idioma:eng
[Mh] Termos MeSH primário: Anticoncepcionais
Serviços de Planejamento Familiar
[Mh] Termos MeSH secundário: Anticoncepção
Acesso aos Serviços de Saúde
Seres Humanos
[Pt] Tipo de publicação:LETTER; COMMENT
[Nm] Nome de substância:
0 (Contraceptive Agents)
[Em] Mês de entrada:1803
[Cu] Atualização por classe:180305
[Lr] Data última revisão:
180305
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:180214
[St] Status:MEDLINE
[do] DOI:10.1136/bmj.k285


  3 / 3655 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28464850
[Au] Autor:Vermandere H; Galle A; Griffin S; de Melo M; Machaieie L; Van Braeckel D; Degomme O
[Ad] Endereço:International Centre for Reproductive Health, Ghent University, De Pintelaan 185, Post: UZP114, 9000, Gent, Belgium. Heleen.vermandere@ugent.be.
[Ti] Título:The impact of facility audits, evaluation reports and incentives on motivation and supply management among family planning service providers: an interventional study in two districts in Maputo Province, Mozambique.
[So] Source:BMC Health Serv Res;17(1):313, 2017 05 02.
[Is] ISSN:1472-6963
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:BACKRGOUND: Good progress is being made towards universal access to contraceptives, however stock-outs still jeopardize progress. A seldom considered but important building block in optimizing supply management is the degree to which health workers feel motivated and responsible for monitoring supply. We explored how and to what extent motivation can be improved, and the impact this can have on avoiding stock-outs. METHODS: Fifteen health facilities in Maputo Province, Mozambique, were divided into 3 groups (2 intervention groups and 1 control), and 10 monthly audits were implemented in each of these 15 facilities to collect data through examination of stock cards and stock-counts of 6 contraceptives. Based on these audits, the 2 intervention groups received a monthly evaluation report reflecting the quality of their supply management. One of these 2 groups was also awarded material incentives conditional on their performance. A Wilcoxon-Mann Whitney test was used to detect differences between the groups in the average number of stocked-out centres, while changes over time were verified through applying a Friedman test. Additionally, staff motivation was measured through interviewing health care providers of all centres at baseline, and after 5 and 10 months. To detect differences between the groups and changes over time, a Kruskal Wallis and a Wilcoxon signed-rank test were applied, respectively. RESULTS: Motivation reported by providers (n = 55, n = 40 and n = 39 at baseline, 1st and 2nd follow-up respectively) was high in all groups, during all rounds, and did not change over time. Facilities in the intervention groups had better supply management results (including less stock-outs) during the entire intervention period compared with those in the control group, but the difference was only significant for the group receiving both material incentives and a monthly evaluation. However, our data also suggest that supply management also improved in control facilities, receiving only a monthly audit. During this study, more stock-outs occurred for family planning methods with lower demand, but the number of stock-outs per family planning method in the intervention groups was only significantly lower, compared with the control group, for female condoms. CONCLUSIONS: While a rise in motivation was not measurable, stock management was enhanced possibly as a result of the monthly audits. This activity was primarily for data collection, but was described as motivating and supportive, indicating the importance of feedback on health workers' accomplishments. More research is needed to quantify the additional impact of the interventions (distribution of evaluation reports and material incentives) on staff motivation and supply management. Special attention should be paid to supply management of less frequently used contraceptive methods.
[Mh] Termos MeSH primário: Auditoria Clínica
Anticoncepcionais/provisão & distribuição
Serviços de Planejamento Familiar/organização & administração
Administração de Instituições de Saúde
Pessoal de Saúde
Motivação
[Mh] Termos MeSH secundário: Equipamentos e Provisões
Estudos de Avaliação como Assunto
Feminino
Pesquisa sobre Serviços de Saúde
Seres Humanos
Moçambique
Qualidade da Assistência à Saúde
Estatísticas não Paramétricas
[Pt] Tipo de publicação:JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T
[Nm] Nome de substância:
0 (Contraceptive Agents)
[Em] Mês de entrada:1712
[Cu] Atualização por classe:180117
[Lr] Data última revisão:
180117
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170504
[St] Status:MEDLINE
[do] DOI:10.1186/s12913-017-2222-3


  4 / 3655 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29016515
[Au] Autor:Moniz MH; Gavin LE; Dalton VK
[Ad] Endereço:Department of Obstetrics and Gynecology, the Program on Women's Healthcare Effectiveness Research, and the Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan.
[Ti] Título:Performance Measures for Contraceptive Care: A New Tool to Enhance Access to Contraception.
[So] Source:Obstet Gynecol;130(5):1121-1125, 2017 Nov.
[Is] ISSN:1873-233X
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Contraception is an essential health service for reducing unintended pregnancy rates, improving health outcomes, and reducing health care costs. However, contraceptive services may not consistently provide access to the full method mix and to patient-centered care. Improving the quality of contraceptive care is a critical strategy to improve contraceptive use, health outcomes, and the patient experience of care. We here describe the three National Quality Forum-endorsed performance measures for contraceptive care, which are intended to monitor 1) provision of most and moderately effective methods, 2) access to long-acting reversible contraception, and 3) provision of most and moderately effective methods and access to long-acting reversible contraception after childbirth. These contraceptive care measures are designed to ensure that contraceptive care is accessible and offers the full spectrum of methods. Payers, health care systems, public agencies, and researchers could all monitor these performance measures for different populations. We describe the crucial role of clinicians in disseminating and using the contraceptive care performance measures for quality improvement. We describe ongoing efforts to improve contraceptive care quality, including the development of measures to monitor other dimensions of quality such as the safety and patient-centeredness of care. Thirty-eight million women at risk of unintended pregnancy are counting on us to improve the quality of family planning care in the United States and ensure that all women have the resources and tools to make free, informed choices about whether and when to become pregnant.
[Mh] Termos MeSH primário: Comportamento Contraceptivo/estatística & dados numéricos
Anticoncepção/normas
Serviços de Planejamento Familiar/normas
Acesso aos Serviços de Saúde/normas
Assistência Centrada no Paciente/normas
[Mh] Termos MeSH secundário: Anticoncepção/métodos
Anticoncepcionais/uso terapêutico
Serviços de Planejamento Familiar/métodos
Feminino
Seres Humanos
Assistência Centrada no Paciente/métodos
Gravidez
Taxa de Gravidez
Gravidez não Planejada
Estados Unidos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Contraceptive Agents)
[Em] Mês de entrada:1711
[Cu] Atualização por classe:171102
[Lr] Data última revisão:
171102
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:171011
[St] Status:MEDLINE
[do] DOI:10.1097/AOG.0000000000002314


  5 / 3655 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28985619
[Au] Autor:Abbo BG; Hulslander LE; Goldade DA
[Ad] Endereço:U.S. Department of Agriculture, Animal and Plant Health Inspection Service, National Wildlife Research Center, Fort Collins, CO, 80521, USA. Electronic address: Benjamin.Abbo@aphis.usda.gov.
[Ti] Título:Determination of 20, 25-diazacholesterol in avian matrices by high performance liquid chromatography/tandem mass spectrometry.
[So] Source:J Chromatogr B Analyt Technol Biomed Life Sci;1065-1066:129-133, 2017 Oct 15.
[Is] ISSN:1873-376X
[Cp] País de publicação:Netherlands
[La] Idioma:eng
[Ab] Resumo:Wildlife contraceptives are an emerging tool for minimizing human-wildlife conflicts. One promising avian contraceptive compound, 20,25-diazacholesterol (DAC), reduces fertility by inhibiting cholesterol synthesis. A reliable analytical method for DAC was required in support of its registration for use as a reproductive control agent in pest bird species. A liquid chromatographic method employing tandem mass spectrometry (LC-MS/MS) was developed for the analysis of tissue extracts following solid phase extraction clean-up. Tissues analyzed were whole body samples from crows, monk parakeets, and quails and liver samples from crows and quails. Excellent sensitivity and selectivity was afforded by tandem mass spectrometry. The method accuracy of DAC from various tissue samples fortified at parts-per-million (ppm) and parts-per-billion (ppb) concentrations was high (>90%) with excellent precision (<10% relative standard deviation). Lower limits of detection were excellent in all tissues types, ranging from 1 to 11ppb in whole body matrices and 9.9-34ppb in liver matrices.
[Mh] Termos MeSH primário: Azacosterol/análise
Aves
Cromatografia Líquida de Alta Pressão/métodos
Anticoncepcionais/análise
Espectrometria de Massas em Tandem/métodos
[Mh] Termos MeSH secundário: Animais
Limite de Detecção
Modelos Lineares
Fígado/química
Controle de Pragas
Reprodutibilidade dos Testes
Extração em Fase Sólida/métodos
Distribuição Tecidual
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Contraceptive Agents); EPT876J73A (Azacosterol)
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171030
[Lr] Data última revisão:
171030
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171007
[St] Status:MEDLINE


  6 / 3655 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28973592
[Au] Autor:Rusterholz C
[Ad] Endereço:Birkbeck University, Swiss National Science Foundation, Powis square 36F, W112AY London.
[Ti] Título:Testing the Gräfenberg Ring in Interwar Britain: Norman Haire, Helena Wright, and the Debate over Statistical Evidence, Side Effects, and Intra-uterine Contraception.
[So] Source:J Hist Med Allied Sci;72(4):448-467, 2017 Oct 01.
[Is] ISSN:1468-4373
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:This paper examines the introduction to Britain of the Gräfenberg ring, an early version of what later became known as an intrauterine device (IUD). The struggle during the interwar years to establish the value of the ring provides an opportunity for a case study of the evaluation and acceptance of a new medical device. With the professionalization of the birth control movement and the expansion of birth control clinics in interwar Britain, efforts to develop better scientific means for contraception grew rapidly. At the end of the nineteenth century, methods for controlling fertility ranged from coitus interruptus and abstinence, to diverse substances ingested or placed into the vagina, to barrier methods. The first decades of the twentieth century brought early work on chemical contraceptives as well as a number of new intrauterine devices, among them the Gräfenberg ring. Developing a cheap, reliable, and widely acceptable contraceptive became a pressing goal for activists in the voluntary birth control movement in Britain between the wars. Yet, tensions developed over the best form of contraception to prescribe. By situating the Gräfenberg ring within the context of the debates and competition among British medical and birth control professionals, this paper reveals broader issues of power relationships and expertise in the assessment of a new medical technology.
[Mh] Termos MeSH primário: Anticoncepção/história
Dispositivos Intrauterinos/história
[Mh] Termos MeSH secundário: Tecnologia Biomédica
Anticoncepcionais/história
Economia
Serviços de Planejamento Familiar
Feminino
Fertilidade
História do Século XIX
História do Século XX
Seres Humanos
Dispositivos Intrauterinos/efeitos adversos
Pesquisa
Reino Unido
[Pt] Tipo de publicação:BIOGRAPHY; HISTORICAL ARTICLE; JOURNAL ARTICLE
[Ps] Nome de pessoa como assunto:Haire N; Wright H
[Nm] Nome de substância:
0 (Contraceptive Agents)
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171025
[Lr] Data última revisão:
171025
[Sb] Subgrupo de revista:IM; QIS
[Da] Data de entrada para processamento:171004
[St] Status:MEDLINE
[do] DOI:10.1093/jhmas/jrx044


  7 / 3655 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28892506
[Au] Autor:Bjelland EK; Owe KM; Nordeng HME; Engdahl BL; Kristiansson P; Vangen S; Eberhard-Gran M
[Ad] Endereço:Health Services Research Unit, Akershus University Hospital, Lørenskog, Norway.
[Ti] Título:Does progestin-only contraceptive use after pregnancy affect recovery from pelvic girdle pain? A prospective population study.
[So] Source:PLoS One;12(9):e0184071, 2017.
[Is] ISSN:1932-6203
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:OBJECTIVE: To estimate associations of progestin-only contraceptives with persistent pelvic girdle pain 18 months after delivery. METHODS: Prospective population based cohort study during the years 2003-2011. We included 20,493 women enrolled in the Norwegian Mother and Child Cohort Study who reported pelvic girdle pain in pregnancy week 30. Data were obtained by 3 self-administered questionnaires and the exposure was obtained by linkage to the Prescription Database of Norway. The outcome was pelvic girdle pain 18 months after delivery. RESULTS: Pelvic girdle pain 18 months after delivery was reported by 9.7% (957/9830) of women with dispense of a progestin-only contraceptive and by 10.5% (1114/10,663) of women without dispense (adjusted odds ratio 0.93; 95% CI 0.84-1.02). In sub-analyses, long duration of exposure to a progestin intrauterine device or progestin-only oral contraceptives was associated with reduced odds of persistent pelvic girdle pain (Ptrend = 0.021 and Ptrend = 0.005). Conversely, long duration of exposure to progestin injections and/or a progestin implant was associated with modest increased odds of persistent pelvic girdle pain (Ptrend = 0.046). Early timing of progestin-only contraceptive dispense following delivery (≤3 months) was not significantly associated with persistent pelvic girdle pain. CONCLUSIONS: Our findings suggest a small beneficial effect of progestin intrauterine devices and progestin-only oral contraceptives on recovery from pelvic girdle pain. We cannot completely rule out an opposing adverse effect of exposure to progestin injections and/or progestin implants. However, the modest increased odds of persistent pelvic girdle pain among these users could be a result of unmeasured confounding.
[Mh] Termos MeSH primário: Anticoncepcionais/uso terapêutico
Dor da Cintura Pélvica/tratamento farmacológico
Dor da Cintura Pélvica/epidemiologia
Progestinas/uso terapêutico
[Mh] Termos MeSH secundário: Adulto
Feminino
Seres Humanos
Dispositivos Intrauterinos
Noruega/epidemiologia
Vigilância da População
Gravidez
Estudos Prospectivos
Resultado do Tratamento
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Contraceptive Agents); 0 (Progestins)
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171018
[Lr] Data última revisão:
171018
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170912
[St] Status:MEDLINE
[do] DOI:10.1371/journal.pone.0184071


  8 / 3655 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28716469
[Au] Autor:Trussell J
[Ad] Endereço:Office of Population Research, Princeton University. Electronic address: trussell@princeton.edu.
[Ti] Título:Validated contraceptive knowledge assessment.
[So] Source:Contraception;96(4):260, 2017 10.
[Is] ISSN:1879-0518
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Anticoncepcionais
Dispositivos Anticoncepcionais
[Mh] Termos MeSH secundário: Anticoncepção
Comportamento Contraceptivo
Conhecimentos, Atitudes e Prática em Saúde
Seres Humanos
[Pt] Tipo de publicação:LETTER; RESEARCH SUPPORT, N.I.H., EXTRAMURAL; COMMENT
[Nm] Nome de substância:
0 (Contraceptive Agents)
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171019
[Lr] Data última revisão:
171019
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170719
[St] Status:MEDLINE


  9 / 3655 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28674592
[Au] Autor:Ntambue AM; Tshiala RN; Malonga FK; Ilunga TM; Kamonayi JM; Kazadi ST; Matungulu CM; Musau AN; Mulamba D; Dramaix-Wilmet M; Donnen P
[Ad] Endereço:Unité d'Epidémiologie et de Santé de la Mère, du Nouveau-né et de l'Enfant, Ecole de Santé Publique, Université de Lubumbashi, Lubumbashi, RDC.
[Ti] Título:[Use of modern contraceptive methods in the Democratic Republic of the Congo: prevalence and barriers in the health zone of Dibindi, Mbuji-Mayi].
[Ti] Título:Utilisation des méthodes contraceptives modernes en République Démocratique du Congo: prévalence et barrières dans la zone de santé de Dibindi à Mbuji-Mayi..
[So] Source:Pan Afr Med J;26:199, 2017.
[Is] ISSN:1937-8688
[Cp] País de publicação:Uganda
[La] Idioma:fre
[Ab] Resumo:INTRODUCTION: This study aimed to determine modern contraceptive prevalence and the barriers to using modern contraceptive methods among the couples in Dibindi health zone, Mbuji-Mayi, in the Democratic Republic of the Congo. METHODS: We conducted a cross-sectional descriptive study from May to June 2015. Nonpregnant married women aged 15-49 years old at the time of the investigation, living in Dibindi health zone for two years and having freely consented to participate in the study were included. Data were collected by open-ended interview of these women. Modern contraceptive prevalence was referred to women who were currently using, at the time of the investigation, modern contraceptives. The comparison between proportions was performed at the significance threshold of 5%. Bonferroni's test was used to compare, two by two, the proportions of barriers to using modern contraceptive methods. RESULTS: Modern contraceptive prevalence in Dibindi was 18.4% in 2015. It was low with regard to family planning services available in this health zone. Several women refused to use modern contraceptive methods despite available information because of their desire for motherhood, religious prohibition, opposition on the part of their husband and fear of side effects. CONCLUSION: Sufficient client-centered or couple-centered information and family planning information should be strengthened in order to eliminate the false beliefs and to increase the use of modern contraceptive methods.
[Mh] Termos MeSH primário: Comportamento Contraceptivo/estatística & dados numéricos
Anticoncepção/métodos
Anticoncepcionais/administração & dosagem
Serviços de Planejamento Familiar
[Mh] Termos MeSH secundário: Adolescente
Adulto
Anticoncepção/utilização
Estudos Transversais
República Democrática do Congo
Feminino
Seres Humanos
Entrevistas como Assunto
Meia-Idade
Prevalência
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Contraceptive Agents)
[Em] Mês de entrada:1707
[Cu] Atualização por classe:170717
[Lr] Data última revisão:
170717
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170705
[St] Status:MEDLINE
[do] DOI:10.11604/pamj.2017.26.199.10897


  10 / 3655 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28604507
[Au] Autor:Parker EC; Kong K; Watts LA; Schwarz EB; Darney PD; Thiel de Bocanegra H
[Ad] Endereço:Emese C. Parker, RN, NP, MPH, is Family Planning Specialist, Bixby Center for Global Reproductive Health and Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco. Kevin Kong, MPH, was Senior Statistician, Bixby Center for Global Reproductive Health, University of California, San Francisco, at the time the study was completed. He is now Analyst, Kaiser Permanente, Oakland, California. Leslie A. Watts, MS, CPC, is Analyst, Bixby Center for Global Reproductive Health and Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco. Eleanor B. Schwarz, MD, MS, is Professor, Department of Internal Medicine, University of California, Davis. Philip D. Darney, MD, MSc, is Distinguished Professor, Department of Obstetrics, Gynecology, and Reproductive Services, and Director, Bixby Center for Global Reproductive Health, University of California, San Francisco. Heike Thiel de Bocanegra, PhD, MPH, is Associate Professor, Bixby Center for Global Reproductive Health and Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, and Director, Family Planning Research Program, Obstetrics and Gynecology, University of California, Irvine.
[Ti] Título:Visits to Registered Nurses: An Opportunity to Increase Contraceptive Access in California.
[So] Source:Nurs Res;66(4):286-294, 2017 Jul/Aug.
[Is] ISSN:1538-9847
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: In 2013, California passed Assembly Bill (A.B.) 2348, approving registered nurses (RNs) to dispense patient self-administered hormonal contraceptives and administer injections of hormonal contraceptives. The Family Planning, Access, Care and Treatment (Family PACT) program, which came into effect in 1997 to expand low-income, uninsured California resident access to contraceptives at no cost, is one program in which qualified RNs can dispense and administer contraceptives. AIMS: The aims of this study were to (a) describe utilization of RN visits within California's Family PACT program and (b) evaluate the impact of RN visits on client birth control acquisition during the first 18 months after implementation of A.B. 2348 (January 1, 2013 to June 30, 2014). METHODS: A descriptive observational design using administrative databases was used. Family PACT claims were retrieved for RN visits and contraception. Paid claims for contraceptive dispensing and/or administration visits by physicians, nurse practitioners, certified nurse midwives, and physician assistants were compared before and after the implementation of A.B. 2348 at practice sites where RN visits were and were not utilized. Contraceptive methods and administration procedures were identified using Healthcare Common Procedure Coding System codes, National Drug Codes, and Common Procedural Terminology codes. Claims data for healthcare facilities were abstracted by site location based on a unique combination of National Provider Identifier (NPI), NPI Owner, and NPI location number. RESULTS: RN visits were found mainly in Northern California and the Central Valley (73%). Sixty-eight percent of RN visits resulted in same-day dispensing and/or administration of hormonal (and/or barrier) methods. Since benefit implementation, RN visits resulted in a 10% increase in access to birth control dispensing and/or administration visits. RN visits were also associated with future birth control acquisition and other healthcare utilization within the subsequent 30 days. DISCUSSION: RN visits, though underutilized across the state, have resulted in increased access to contraception in some communities, an effect that may continue to grow with time and can serve as a model for other states.
[Mh] Termos MeSH primário: Anticoncepção/métodos
Anticoncepcionais
Assistência à Saúde/legislação & jurisprudência
Prescrições de Medicamentos/normas
Serviços de Planejamento Familiar/legislação & jurisprudência
Enfermeiras e Enfermeiros/legislação & jurisprudência
Enfermeiras e Enfermeiros/normas
[Mh] Termos MeSH secundário: Adolescente
Adulto
California
Feminino
Seres Humanos
Masculino
Meia-Idade
Planos Governamentais de Saúde
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Contraceptive Agents)
[Em] Mês de entrada:1707
[Cu] Atualização por classe:170919
[Lr] Data última revisão:
170919
[Sb] Subgrupo de revista:AIM; IM; N
[Da] Data de entrada para processamento:170613
[St] Status:MEDLINE
[do] DOI:10.1097/NNR.0000000000000229



página 1 de 366 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde